C
PhenixFIN Corporation PFX
$53.07 $0.200.38% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

Company Overview

PhenixFIN Corporation (NASDAQ: PFX) is a publicly traded non-diversified closed-end management investment company that has elected to be regulated as a business development company (BDC) under the Investment Company Act of 1940. The company focuses primarily on providing debt and equity capital to middle-market companies, with an emphasis on private credit investments, structured financing, and opportunistic special situations. Its investment strategy is designed to generate current income and capital appreciation through investments in privately negotiated senior secured debt, subordinated debt, and equity-related instruments.

The company traces its origins to Medley Capital Corporation before rebranding as PhenixFIN Corporation in 2021 following changes in management and strategic direction. PhenixFIN’s portfolio historically has included investments across sectors such as business services, healthcare, manufacturing, technology, and consumer-related industries. Its positioning within the alternative credit and middle-market lending space allows it to pursue customized financing structures for companies that may have limited access to traditional bank financing.

Business Operations

PhenixFIN generates revenue primarily through interest income, fee income, dividend income, and realized or unrealized gains on investments. Its portfolio generally consists of directly originated loans and opportunistic credit investments targeting middle-market borrowers in the United States. As a BDC, the company is required to distribute a substantial portion of taxable income to shareholders, making investment income generation a core operational objective. The company’s operations are principally investment-focused rather than product-manufacturing or consumer-service based.

The company’s investment activities are managed internally, and its assets include secured loans, subordinated debt instruments, and equity positions. PhenixFIN has historically maintained exposure to both performing credit assets and distressed or special situation opportunities. Public filings indicate that the company’s operations are primarily domestic, with investment exposure concentrated in U.S.-based businesses. Data regarding major international joint ventures or large-scale operating subsidiaries is inconclusive based on available public sources.

Strategic Position & Investments

PhenixFIN’s strategic direction has centered on portfolio optimization, capital preservation, and disciplined underwriting within the middle-market credit sector. The company has focused on reducing legacy underperforming assets while selectively deploying capital into higher-yielding and risk-adjusted opportunities. Management commentary in public filings has emphasized liquidity management, net asset value stabilization, and improving long-term shareholder returns through selective originations and active portfolio monitoring.

The company’s investment portfolio has included both directly originated loans and opportunistic investments in companies requiring flexible financing solutions. PhenixFIN has also maintained investments in sectors benefiting from long-term structural demand, including healthcare services and specialized business services. Unlike larger diversified alternative asset managers, PhenixFIN operates with a relatively concentrated portfolio structure, which can increase exposure to individual investment outcomes. Data regarding significant acquisitions, large portfolio company ownership stakes, or major technology-sector ventures remains limited in publicly available disclosures.

Geographic Footprint

PhenixFIN is headquartered in New York, United States, and its investment activities are primarily concentrated within the U.S. middle market. The company’s borrowers and portfolio companies generally operate across multiple domestic industries and regions, including manufacturing, healthcare, business services, and consumer sectors. Its operational footprint is therefore largely tied to the geographic distribution of its investment portfolio rather than physical branch infrastructure.

The company does not maintain the broad multinational operating presence commonly associated with large industrial or technology corporations. Public disclosures indicate that most investments are U.S.-based, though some portfolio companies may have international commercial operations. Data concerning material direct operational exposure outside the United States is inconclusive based on available public sources.

Leadership & Governance

PhenixFIN is governed by a board of directors and executive management team responsible for investment strategy, portfolio oversight, compliance, and capital allocation. Following its transition from Medley Capital Corporation, the company adopted a more internally focused management structure intended to align operations and shareholder interests. Public company governance practices include oversight through board committees, regulatory reporting obligations, and compliance with BDC-related investment restrictions under U.S. securities laws.

Key executives and leadership figures include:

  • David Lorber – Chief Executive Officer and President
  • Molly Langenstein – Chief Financial Officer and Treasurer
  • Patrick Lawlor – Chief Compliance Officer and Secretary

Management’s stated strategic priorities have included disciplined capital deployment, portfolio risk management, and enhancing long-term net asset value performance. The company’s governance framework and operational disclosures are primarily documented through SEC filings, including annual reports on Form 10-K and quarterly reports on Form 10-Q.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $209.66
B
AAPL NASDAQ $313.45
B
AVGO NASDAQ $355.59
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $104.34
Top Financial Stocks
See All »
B
B
JPM NYSE $356.50
B
V NYSE $383.90
Top Energy Stocks
See All »
B
CVX NYSE $200.21
B
BPAQF OTC PK $7.08
Top Health Care Stocks
See All »
B
LLY NYSE $1,189.41
B
JNJ NYSE $270.00
B
ABBV NYSE $262.90
Top Real Estate Stocks
See All »
B
PLD NYSE $142.59
B
EQIX NASDAQ $1,079.61